Dumic-Cule, Ivo
Peric, Mihaela
Kucko, Lucija
Grgurevic, Lovorka
Pecina, Marko
Vukicevic, Slobodan
Article History
Received: 5 September 2018
Accepted: 7 September 2018
First Online: 15 September 2018
Compliance with ethical standards
:
: IDC, LK, and Marko Pecina declare no conflict of interest. Mihaela Peric is employed by School of Medicine, University of Zagreb and is actively involved in OSTEOproSPINE program and clinical testing in patients with posterolateral spinal fusion. LG is employed by School of Medicine, University of Zagreb and actively leads the development of the final Osteogrow drug product in patients with distal radius fracture, high tibial osteotomy, and lumbar back pain. SV is employed by School of Medicine, University of Zagreb and is founder of Genera Research, a Croatian biotechnology company conducting clinical trials with Osteogrow.